S&P 100
3.327,47
PKT
+23,80
PKT
+0,72
%
Werbung
Analysen zu S&P 100-Werten
Datum | Rating | Analyst | |
---|---|---|---|
04.10.18 | Amgen Neutral | Cantor Fitzgerald | |
04.10.18 | Amazon buy | Jefferies & Company Inc. | |
04.10.18 | HP Buy | Maxim Group | |
04.10.18 | Linde buy | UBS AG | |
04.10.18 | Pfizer Halten | Independent Research GmbH | |
04.10.18 | Linde verkaufen | Bernstein Research | |
03.10.18 | Tesla buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
03.10.18 | Nike Hold | HSBC | |
03.10.18 | Amazon Conviction Buy | Goldman Sachs Group Inc. | |
02.10.18 | Tesla Sector Perform | RBC Capital Markets | |
02.10.18 | Tesla Peer Perform | Wolfe Research | |
02.10.18 | ExxonMobil buy | Société Générale Group S.A. (SG) | |
02.10.18 | ExxonMobil Neutral | Credit Suisse Group | |
02.10.18 | Coca-Cola buy | Morningstar | |
02.10.18 | Amgen Outperform | Oppenheimer & Co. Inc. | |
02.10.18 | Comcast Buy | Pivotal Research Group | |
02.10.18 | Linde Outperform | BNP PARIBAS | |
02.10.18 | Linde buy | Société Générale Group S.A. (SG) | |
02.10.18 | Netflix buy | Goldman Sachs Group Inc. | |
01.10.18 | Pfizer overweight | JP Morgan Chase & Co. | |
01.10.18 | Tesla Sector Perform | RBC Capital Markets | |
01.10.18 | Tesla Equal-Weight | Morgan Stanley | |
01.10.18 | Tesla Underweight | Barclays Capital | |
01.10.18 | Tesla Sell | Morningstar | |
01.10.18 | Tesla Outperform | Oppenheimer & Co. Inc. | |
01.10.18 | Nike Sell | Morningstar | |
01.10.18 | Netflix Outperform | Credit Suisse Group | |
01.10.18 | Microsoft Outperform | Wells Fargo & Co | |
01.10.18 | Microsoft Outperform | Credit Suisse Group | |
01.10.18 | Intel buy | Morningstar | |
01.10.18 | Intel Outperform | Wells Fargo & Co | |
01.10.18 | Intel Hold | Stifel, Nicolaus & Co., Inc. | |
01.10.18 | Intel overweight | JP Morgan Chase & Co. | |
01.10.18 | Intel Sector Perform | RBC Capital Markets | |
01.10.18 | Meta Platforms (ex Facebook) Outperform | Wells Fargo & Co | |
01.10.18 | Apple neutral | Wells Fargo & Co | |
01.10.18 | Apple Outperform | Macquarie Research | |
01.10.18 | Apple neutral | Oppenheimer & Co. Inc. | |
01.10.18 | Gilead Sciences Overweight | Cantor Fitzgerald | |
01.10.18 | Amgen buy | Jefferies & Company Inc. |